Forgot your password?

Forgot your username?

database > company
Ariad Pharmaceuticals
Biotech Specialty Pharma
26 Landsdowne Street
Cambridge, MA 02139-4234 USA
Click for website
Research Sector Biotech Specialty Pharma
Summary Description
Medicines to treat cancer by regulating cell signaling with small molecules.
Click here for Financial Data
ridaforolimus, deforolimus, angiogenesis, metabolism, endometrial


Their focus at ARIAD is to discover and develop new drugs that will dramatically expand and improve current treatment options for patients with cancer. Their story starts with our vision, which reflec......view more

Products / Services

Ariad's lead product candidate, AP23573, is a novel, potent mTOR inhibitor in development for multiple oncology indications.......view more

Technology / Differentiation

Its proprietary portfolio of cell-signaling regulation technologies includes the ARGENT signaling and transcription technologies.It has an exclusive license to pioneering technology and patents relate...view more

Market / Customers

Each year more than 1 million people are diagnosed with cancer.......view more

Competitors / Substitutes / Alternatives

Chiron Corp (CHIR), Genzyme Corp (GENZ)...view more